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ceAn important component of routine preventive care for children is the monitoring of growth and
development. Although cognitive, affective, and behavioral health problems are commonly
encountered in pediatric primary care, there is debate around issues related to early detection of
signiﬁcant problems of this type, including the accuracy of screening and the beneﬁts and harms of
early diagnosis and treatment. The U.S. Preventive Services Task Force makes recommendations
regarding clinical preventive services for primary care clinicians based on the best available scientiﬁc
evidence. The Task Force has found important gaps related to the validity of commonly used
screening tools and signiﬁcant gaps related to the evidence regarding early treatment. This review
describes the meaning of the grades used by the Task Force, how these grades are determined, and
the grades assigned to childhood cognitive, affective, and behavioral health recommendations. The
review summarizes common themes in the evidence gaps and the future research necessary to
advance the ﬁeld and improve child health outcomes.
(Am J Prev Med 2016;51(4S2):S119–S123) & 2016 American Journal of Preventive Medicine. Published by
Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).IntroductionIn the U.S., pediatric preventive care is generallydelivered through a series of preventive healthcarevisits. There are now 31 recommended visits from
the newborn period through age 21 years.1 The frequency
and spacing of visits allow for a wide array of speciﬁcally
timed preventive services, including screening, counsel-
ing, and anticipatory guidance. In addition, the repeated
visits allow healthcare providers to monitor growth and
development over time, a process referred to as surveil-
lance. Clinical preventive services can improve health
outcomes during childhood and adolescence and have a
lifelong impact. Weighing the beneﬁts and harms of
preventive services can be challenging because of a lack of
data from research trials and the difﬁculty in assessing
health beneﬁts, especially long-term, in children and
adolescents.$36.00
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rican Journal of Preventive Medicine. Published by Elsevie
ss article under the CC BY-NC-ND license (http://creativThe goals of this review are to provide a brief overview
of the U.S. Preventive Services Task Force (USPSTF)
recommendation process; to summarize the USPSTF
recommendations related to cognitive, affective, and
behavioral health; and to deﬁne opportunities for
addressing the signiﬁcant gaps identiﬁed by the USPSTF
related to screening for these conditions.Overview of the U.S. Preventive Services
Task Force
The USPSTF is a 16-member panel of non-federal
experts in primary care and evidence-based medicine.
Members are appointed by the director of the U.S.
Agency for Healthcare Research and Quality and each
member serves a 4-year term. The USPSTF makes
recommendations regarding preventive care, including
screening tests, counseling, and preventive medications.
To be considered, the preventive care services must be
offered in primary care settings or be preventive care
services that would typically be initiated in the primary
care setting with follow-up by other healthcare providers.
The USPSTF makes recommendations regarding pre-
ventive care services provided to asymptomatic individ-
uals, not those who already have signs or symptoms of a
condition.r Inc. This is
ecommons.org/licenses/by-nc-nd/4.0/).
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opportunities for providing preventive care services out-
side of primary care, especially in community settings.
The Community Preventive Services Task Force was
established in 1996 as an independent body supported
by the Centers for Disease Control and Prevention to
provide recommendations for use in community-based
settings, including schools (www.thecommunityguide.
org).2 The Community Preventive Services Task Force
addresses a broad array of topics related to behavioral
counseling for children and adolescents, including inter-
ventions to reduce sexual risk behaviors, increase motor
vehicle safety, and reduce alcohol and tobacco use.
Although there are some differences in the methods used
by the two Task Forces, each has an overall goal of
improving health through prevention. The key difference
is related to the settings in which the preventive services
are delivered.
The USPSTF bases its recommendations on systematic
evidence reviews using a well-deﬁned and transparent
process.3 The USPSTF does not conduct research. How-
ever, critical research gaps identiﬁed by the USPSTF are
summarized in the recommendation statements and in
its annual report to the U.S. Congress each year.
The USPSTF makes recommendations based on the
certainty of net beneﬁt for the patient resulting from a
speciﬁc preventive care service. Net beneﬁt reﬂects the
expectation of the degree to which beneﬁts exceed harms
from implementation of the service in the primary care
setting and is classiﬁed as substantial, moderate, small, or
zero/negative. Certainty reﬂects the overall evidence
regarding the net beneﬁt. High certainty results from
consistent results from high-quality studies in primary
care settings with a study population reﬂective of the
target of the preventive care service. Moderate certainty
implies that the evidence is sufﬁcient to evaluate the
preventive care service, but the conﬁdence in the
estimates is such that future research could change the
magnitude or direction of the assessment. Low certainty
is assigned when the evidence is insufﬁcient to evaluate
the preventive care service. Insufﬁciency results from the
identiﬁcation of few high-quality studies or of heteroge-
neous ﬁndings.
For pediatric services, the USPSTF often does not
identify direct evidence related to the delivery of a
speciﬁc preventive service and consequent health out-
comes. Such direct evidence could come from a random-
ized trial of screening with sufﬁciently long follow-up to
ascertain differences in patient outcomes. In the absence
of direct evidence, the USPSTF considers key questions
related to the performance characteristics of the preven-
tive service, the relationship of the preventive service
to intermediate or proxy outcomes, the relationshipbetween intermediate or proxy outcomes and long-
term health outcomes, and harms associated with deliv-
ery of the preventive service or health care that might be
delivered as a direct result of the preventive service and
treatment. The USPSTF does not consider costs or
coverage when developing recommendations.4
It is important to recognize that when evaluating the
net beneﬁt of screening, the focus is on long-term
outcomes for those low-risk or average-risk individuals
identiﬁed speciﬁcally through screening. However, most
treatment studies focus on outcomes frommore–severely
affected children than those expected to be found only
through screening.
To simplify communication about USPSTF recom-
mendations, a letter grade system is used to brieﬂy
communicate ﬁndings, as follows5:A. The USPSTF recommends the service. There is a high
certainty that the net beneﬁt is substantial.B. The USPSTF recommends the service. There is high
certainty that the net beneﬁt is moderate or there is
moderate certainty that the net beneﬁt is moderate to
substantial.C. The USPSTF recommends selectively offering or
providing this service to individual patients based
on professional judgment and patient preferences.
There is at least moderate certainty that the net
beneﬁt is small.D. The USPSTF recommends against the service. There
is moderate or high certainty that the service has no
net beneﬁt or that the harms outweigh the beneﬁts.E. The USPSTF concludes that the current evidence is
insufﬁcient to assess the balance of beneﬁts and harms
of the service. Evidence is lacking, of poor quality, or
conﬂicting, and the balance of beneﬁts and harms
cannot be determined.
The C grade is often confused with the I statement. The
C grade indicates that there may be a small beneﬁt and that
the delivery of the preventive service should be based on
the results of an informed discussion between the patient
or family and the healthcare provider. By contrast, the I
statement is made when there is not sufﬁcient evidence to
make a speciﬁc graded recommendation.
All ﬁnal USPSTF recommendation statements include
a description of the rationale for the preventive service
and the USPSTF’s assessment of the evidence and a
section describing the clinical considerations related to
the preventive service. Primary care providers should
read these statements before modifying the preventive
services that they provide. In addition, the ﬁnal evidence
reviews are available for those interested in a more
complete understanding of the evidence.www.ajpmonline.org
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services with an A or B recommendation are to be
covered without cost sharing by non-grandfathered
contracts offered by group health plans and by health
insurance plans offered in the individual or group market
purchased before the Affordable Care Act became law
(March 23, 2010). As previously described, the USPSTF
does not consider issues related to cost or coverage in
developing recommendations. Although the USPSTF
does not speciﬁcally advocate for coverage of preventive
services, it recognizes the importance of insurance cover-
age in providing access to services and therefore also
recognizes the importance of insurance coverage for a
wider array of preventive services, such as those for
which the balance of beneﬁt and harm is more closely
balanced (i.e., C recommendations) or for those preven-
tive services for which there is insufﬁcient evidence to
assess the overall net beneﬁt (i.e., I statements). A and B
recommended services should be considered the “ﬂoor”
of preventive care delivery, not the “ceiling.”4
The general approach to developing a recommenda-
tion is to begin with developing a research plan, including
an analytic framework and list of key questions. After a
period of public comment, the research plan is ﬁnalized
and a draft evidence report is developed by one of the
U.S. Agency for Healthcare Research and Quality–
funded evidence-based practice centers. The draft evi-
dence review is evaluated and revised based on input
from the USPSTF and then a draft recommendation
statement is produced. The revised evidence review and
draft recommendation statement is then made available
for public comment. The evidence review and recom-
mendation statement are then further revised, ﬁnalized,
and disseminated. To make sure a full range of public
comments are received, the USPSTF distributes requests
for public comments to recognized experts and profes-
sional and other advocacy organizations. In addition,
calls for public comment are advertised on the USPSTF
website (www.uspreventiveservicestaskforce.org/Page/
Name/us-preventive-services-task-force-opportunities-
for-public-comment).
Addressing the Research Gaps
I statements should not be viewed as expressions that a
preventive service should not be done, only that there is
insufﬁcient evidence using the USPSTF methods to
evaluate the net beneﬁt of the preventive service. Most
of these gaps are related to uncertainty regarding treat-
ment outcomes for those identiﬁed speciﬁcally through
screening. The reason for these gaps is understandable.
Scientiﬁc attention is usually ﬁrst put toward developing
effective treatment for the most severely affectedOctober 2016individuals. Later work often then focuses on the devel-
opment of tools for early intervention. Enthusiasm about
adoption can lead to gaps regarding the comparative
beneﬁts of early intervention. There are several strategies
to address this if adoption of screening has already been
adopted. Randomized trials of screening can provide a
high level of evidence, but can be challenging to do if the
preventive service is already considered to be the stand-
ard of care. However, trials in other communities,
including countries similar to the U.S., are often still
feasible. Such trials can be expensive and take a long time
before results are available. Comparing the prevalence of
the targeted condition across different communities that
vary in whether screening is offered can be informative.
However, such studies can be biased based on the degree
to which case ascertainment is systematically done.
Large, population-based retrospective studies can ﬁll in
the gap when it is clear who was screened and when the
outcomes are systematically captured. The move to
electronic medical records facilitates this work, and the
ability to link records across health systems is likely to be
fundamental to these efforts. To help encourage research,
the USPSTF began in 2011 to present an annual report to
Congress that highlights important knowledge gaps. The
fourth annual report focused on children and adolescents
(www.uspreventiveservicestaskforce.org/Page/Name/
reports-to-congress).U.S. Preventive Services Task Force
Recommendations Regarding Childhood
Cognitive, Affective, and Behavioral Health
The following is a description of current USPSTF
recommendations in the domain of childhood cognitive,
affective, and behavioral health. All current recommen-
dations are available on the USPSTF website (www.
uspreventiveservicestaskforce.org).Alcohol Misuse
In 2013, the USPSTF issued an I statement regarding
screening and behavioral counseling interventions to
reduce alcohol misuse among adolescents aged 12–17
years.6 By contrast, a B recommendation was given for
those aged Z18 years owing to evidence showing that
brief behavioral counseling interventions in adults
reduced risky or hazardous drinking. The USPSTF did
not identify high-quality studies that addressed screening
and behavioral counseling interventions for alcohol
misuse in adolescents, a critical gap related to the
effectiveness of interventions delivered in the primary
care setting.
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In 2016, the USPSTF issued an I statement regarding
screening for autism spectrum disorder in young chil-
dren.7 There is a critical gap in evidence regarding
treatment outcomes of children agedo3 years identiﬁed
through screening. The USPSTF found limited evidence
on the potential beneﬁts of screening for autism spec-
trum disorder in this group of asymptomatic young
children. Most studies focused on the beneﬁts of treating
older children who had been identiﬁed by concerned
parents, teachers, or caregivers; these children are likely
to have more severe autism than those who would be
identiﬁed through screening. The USPSTF also found
little evidence about the potential harms of screening
young children for autism spectrum disorder. However,
the potential harms of screening and treating children
identiﬁed through screening are likely to be low.
At the time of release of the statement, published
commentaries by experts in the ﬁeld acknowledged the
limitations of data regarding outcomes of those children
identiﬁed through screening only but also highlighted
the signiﬁcant challenges in systematically determining
the beneﬁt of early intervention resulting directly
from screening.8–11 Two of these commentaries8,11 also
expressed concerns about how the I statement would be
interpreted, and this could delay identiﬁcation and
treatment but exacerbate disparities in outcomes. The
USPSTF would like to underscore that the I statement is
not a call against screening but is a call for more research.
The USPSTF also recognizes that other groups using
different methods to guideline development, including
Bright Futures, recommends autism screening. Under the
Affordable Care Act, Bright Futures recommendations
are also covered preventive services.Depression
In 2016, the USPSTF issued an I statement for screening
for major depressive disorder among children aged 7–11
years and a B recommendation for children aged 12–18
years when systems are in place to ensure accurate
diagnosis, psychotherapy, and follow-up.12 Little is
known about the accuracy of screening tests in children
agedo12 years. Little is also known about the beneﬁt of
detecting depression in young children through screen-
ing or the magnitude of beneﬁt for those young children
identiﬁed through screening. By contrast, there is
adequate evidence that screening can identify adolescents
with depression. The USPSTF also found adequate
evidence that treatment of adolescents with screen-
detected depression is associated with a beneﬁcial reduc-
tion in symptoms. For all children and adolescents, there
is concern about harms, including suicidal events andsuicidal ideation, related to the use of pharmacotherapy.
However, the magnitude of these potential harms is small
with appropriate monitoring.
The USPSTF also issued a B statement for maternal
depression screening in adults, which includes screening
for maternal depression.13 In addition to improving
outcomes for the mother, reducing maternal depression
could have important beneﬁts for the infant.Illicit Drug Use
In 2014, the USPSTF issued an I statement about the use
of behavioral interventions to prevent or reduce illicit
drug use among children and adolescents.14 There is a
critical evidence gap resulting from the limited and
inconsistent evidence available on the effectiveness of
interventions used in primary care settings or available
through referral by primary care providers. Little is also
known about the tools to identify those at risk or already
engaging in illicit drug use.Speech and Language Delay and Disorders in
Preschool-Aged Children
In 2015, the USPSTF issued an I statement regarding
screening for speech and language delay and disorders in
children aged r5 years.15 The USPSTF identiﬁed critical
evidence gaps related to the performance of available
screening instruments and the effectiveness of early inter-
vention. Most studies were based on individuals who were
clinically identiﬁed instead of asymptomatic children iden-
tiﬁed through screening, and the treatment studies had
large loss to follow-up rates.Suicide Risk
In 2014, the USPSTF issued an I statement regarding
screening for suicide risk in adolescents.16 Critical
evidence gaps included inadequate evidence on the
accuracy of screening tests, the effectiveness of treatment,
and the harms of screening or treatment. The USPSTF
also suggested evaluating the effectiveness of linking
primary care to community resources to provide services
for those at risk of suicide as an area of research.Tobacco Use in Children and Adolescents
In 2013, the USPSTF issued a B recommendation for
providing education and counseling to prevent the
initiation of tobacco use.17 Although the USPSTF found
adequate evidence that behavioral counseling interven-
tions can reduce the risk of smoking initiation in school-
aged children and adolescents, it also recognized the
future opportunity to assess the effectiveness of referral
to computer-based interventions that could be tailored towww.ajpmonline.org
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tobacco use.
Summary and Implications
The USPSTF has evaluated only a subset of the possible
preventive services available for children and adolescents
related to cognitive, affective, and behavioral health, and
for many of those that were evaluated, the USPSTF found
insufﬁcient evidence to make a speciﬁc recommendation.
The common gaps in evidence include lack of informa-
tion about screening accuracy and inadequate evidence
about the effectiveness of intervention for asymptomatic
individuals identiﬁed through screening in the primary
care setting. Trials of screening and other preventive
services are less common for children than adults. The
authors hope that identiﬁcation of these gaps encourages
clinicians and researchers to work together to improve the
quantity and quality of the evidence base in these key areas.
This is not simply an academic exercise. It is imperative
that we not only understand but also continually improve
the effectiveness of our preventive care services.
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